Aura Biosciences (AURA) Other Working Capital Changes (2020 - 2026)
Aura Biosciences (AURA) reported Other Working Capital Changes of -$386000.0 for Q1 2026, down 18.77% on a YoY basis from -$475189.4 in Q1 2025, and up 87.2% quarter-over-quarter from -$3.0 million in Q4 2025.
Aura Biosciences (AURA) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Aura Biosciences has reported Other Working Capital Changes for 7 years, with the latest figure at -$386000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 18.77% year-over-year to -$386000.0; the trailing twelve-month figure through Mar 2026 stood at -$4.1 million (up 15.85% YoY), and the FY2025 full-year result was -$4.0 million, down 411.55% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$386000.0, up from -$3.0 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $4.0 million in Q3 2024, with the low at -$4.3 million in Q2 2024.
- Historically, Other Working Capital Changes has averaged -$204625.0 across 5 years, with a median of -$345000.0 in 2025.
- The largest YoY upside for Other Working Capital Changes was 801.35% in 2024 against a maximum downside of 864.56% in 2024.
- Aura Biosciences' Other Working Capital Changes stood at $3.7 million in 2022, then slumped by 135.31% to -$1.3 million in 2023, then tumbled by 222.52% to -$4.3 million in 2024, then advanced by 29.32% to -$3.0 million in 2025, then soared by 87.2% to -$386000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$386000.0 (Q1 2026), -$3.0 million (Q4 2025), and -$358000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -386,000.00 |
| Mar 31, 2026 | -386,000.00 |
| Dec 31, 2025 | -3.02 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | -358,000.00 |
| Sep 30, 2025 | -358,000.00 |
| Jun 30, 2025 | -332,000.00 |
| Jun 30, 2025 | -332,000.00 |
| Mar 31, 2025 | -325,000.00 |
| Mar 31, 2025 | -325,000.00 |
| Dec 31, 2024 | -4.27 Mn |
| Dec 31, 2024 | -4.27 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Jun 30, 2024 | -4.27 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Mar 31, 2024 | 3.75 Mn |
| Dec 31, 2023 | -1.32 Mn |
| Dec 31, 2023 | -1.32 Mn |